Benchmark fetal bovine serum in 500ML bottles (lot A99C00C)
Ended Awarded
- Contract number
- HHSN26100016
- Awardee
-
Gemini Bioproducts LLC UEI TPLGWKT6AM88
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,294
Award facts
- Contract value 100% obligated
- $5,294.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a Blanket Purchase Agreement (BPA) call to Gemini Bioproducts LLC for benchmark fetal bovine serum in 500 mL bottles (Lot A99C00C) on March 1, 2012, with a ceiling value of $5,294.00. This fixed-price contract with economic price adjustment provisions was set to be completed by May 31, 2012, with performance taking place at the National Cancer Institute's facility in Bethesda, Maryland. The contract carries no set-aside designation and represents a call against an existing blanket purchase agreement, enabling efficient procurement of this critical cell culture product.
Gemini Bioproducts LLC, a West Sacramento, California-based supplier of cell culture products and scientific reagents, has established itself as a key vendor to the National Institutes of Health and its component institutes since 2001. Fetal bovine serum is an essential component in cell culture research used across biomedical and cancer research applications. This award reflects the National Cancer Institute's reliance on Gemini Bioproducts' established capability to supply high-quality biological reagents necessary for ongoing research operations, consistent with the company's broader track record of providing critical materials to federal research institutions.
Quick answers
Who was awarded contract HHSN26100016?
HHSN26100016 was awarded to Gemini Bioproducts LLC by National Cancer Institute (National Institutes of Health) on March 1, 2012.
How much is contract HHSN26100016 worth?
The government has obligated $5,294 on HHSN26100016.
Is contract HHSN26100016 an order under another contract?
Yes. HHSN26100016 is a BPA call under HHSN263199700048255B, a blanket purchase agreement.
Was contract HHSN26100016 competed?
The extent of competition for HHSN26100016 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award